JamesMatthewLutherMDMSCI

Hypertension, Renovascular Medicine

Associate Professor of Medicine and Pharmacology

Dr. Luther is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
3601 21st Ave S
Nashville, TN 37232
Phone+1 615-322-3353

Fax+1 615-936-0605

Dr. James M. Luther is Associate Professor of medicine and pharmacology at Vanderbilt University School of Medicine in Nashville, Tennessee. The focus of his translational research program is to investigate the pathophysiologic links between hypertension and metabolic complications. His clinical focus in the Vanderbilt Hypertension Clinic is to evaluate and treat resistant and secondary hypertension. He is board certified in Medicine and Nephrology.

Dr. Luther received his MD degree from Vanderbilt School of Medicine, where he also completed training in Internal Medicine, Clinical Pharmacology, and Nephrology before joining the faculty in the Division of Clinical Pharmacology. He also received a Masters in Clinical Investigation program at Vanderbilt, and now serves as faculty in the program.

PubMed

2 citations
The subcutaneous adipose transcriptome identifies a molecular signature of insulin resistance shared with visceral adipose.
Mona Mashayekhi, Quanhu Sheng, Samuel S Bailin, Lucas Massier, Jiawei Zhong
Obesity. 2024-08-01
Flow Disturbances: Competing Interests in a Case of Hypertensive Emergency.
Matthew R Alexander, Aaron W Aday, Julia Lewis, Christine J Deyholos, James M Luther
Hypertension. 2024-04-01
6 citations
Unilaterally Successful Adrenal Vein Sampling: Use or Repeat?
James M Luther, Adina F Turcu
Hypertension. 2023-10-01

Books/Book Chapters

The Cleveland Clinic Intensive Review of Internal Medicine
Chapter: Acid Base Disorders
Page 594 - 610Luther JM, Breyer-Lewis JBEditors: Stoller JK, Michota FA, Mandell BF.Lippincott Williams & Wilkins, PhiladelphiaEdition 5th,
Andreoli and Carptentier's Cecil Essentials of Medicine
Chapter: Vascular Diseases of the Kidney
Page 345 - 358Luther JM, Schulman GEditors: Andreoli TE, Benjamin IJ, Griggs RC, Wing EJ.Saunders, PhiladelphiaEdition 8th,
Primer on the Autonomic Nervous System
Chapter: Drug-Induced Autonomic Dysfunction
Page 511 - 514Luther JMEditors: Robertson D, Biaggioni I, Burnstock G, Low PA, Paton JFR.Saunders, PhiladelphiaEdition 3rd,
Vascular Medicine: A Companion to Braunwald’s Heart Disease
Chapter: Vascular Pharmacology
Page 75 - 93Luther JM, Harrison DGEditors: Creagor MA, Beckman JA, Loscalzo J.Saunders, PhiladelphiaEdition 2nd,
Join now to see all

What's Your Approach? MRAs and Chronic Kidney DiseaseJuly 30th, 2023
Diabetes Drug May Improve AsthmaFebruary 21st, 2023
Medicare Reimbursement Policy for Ambulatory Blood Pressure Monitoring: A Qualitative Analysis of Public Comments to the Centers for Medicare and Medicaid ServicesDecember 1st, 2019

Endogenous Aldosterone and glucose metabolismNIH/NIDDK, NHLBI2013–Present
Role of Eicosanoids in Renal FunctionNIH/NIDDK2009–Present
Aldosterone And Glucose MetabolismNational Institute Of Diabetes And Digestive And Kidney Diseases2008–2011